ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,832Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1211

$421K Total Retail Price of All Prescriptions

Rank: 146 out of 1211

1,006 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,006 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL TARTRATE 763 628 1 4
FUROSEMIDE 618 528 2 7
AMLODIPINE BESYLATE 321 286 3 2
CLOPIDOGREL 304 252 4 10
LOSARTAN POTASSIUM 300 258 5 12
DIGOXIN 272 190 6 15
ATENOLOL 262 226 7 13
SIMVASTATIN 260 225 8 1
ISOSORBIDE MONONITRATE ER 232 186 9 16
NIFEDIPINE ER 220 147 10 43
PLAVIX 220 184 10 14
WARFARIN SODIUM 206 185 12 8
LISINOPRIL 199 153 13 6
CARVEDILOL 198 138 14 3
METOPROLOL SUCCINATE 181 128 15 5
ENALAPRIL MALEATE 165 114 16 28
HYDROCHLOROTHIAZIDE 156 120 17 17
PRADAXA 134 130 18 23
OMEPRAZOLE 131 92 19 20
PRAVASTATIN SODIUM 123 121 20 18
CLONIDINE HCL 117 77 21 34
EFFIENT 107 74 22 86
DILTIAZEM 24HR ER 94 83 23 91
MELOXICAM 91 77 24 88
PANTOPRAZOLE SODIUM 89 74 25 44
NIFEDICAL XL 88 61 26 113
ATORVASTATIN CALCIUM 84 67 27 9
VERAPAMIL ER 77 52 28 77
NITROGLYCERIN PATCH 73 66 29 55
CARTIA XT 72 69 30 76
MIDODRINE HCL 68 68 31 249
SOTALOL 67 67 32 33
BUMETANIDE 67 37 32 71
BYSTOLIC 67 43 32 36
XARELTO 66 63 35 61
LOVASTATIN 65 65 36 37
NITROSTAT 63 40 37 26
BENICAR 62 52 38 69
ADVAIR DISKUS 59 51 39 84
RANEXA 57 41 40 40
CILOSTAZOL 55 52 41 83
AMITRIPTYLINE HCL 54 49 R 42 170
DIOVAN 54 47 42 21
ZOLPIDEM TARTRATE 54 41 42 32
VERAPAMIL HCL 53 41 45 343
SUCRALFATE 52 48 46 347
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.